Print Page

Products found to contain undeclared medicines

The United States: Public Notification: Lyn DTOX FS3 contains hidden drug ingredients sibutramine and N-desmethylsibutramine
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Lyn DTOX FS3, a product promoted for weight loss. This product was identified during an examination of international mail shipments. FDA laboratory analysis confirmed that Lyn DTOX FS3 contains sibutramine and N-desmethylsibutramine. Sibutramine is a controlled substance that was removed from the market in Oct 2010 for safety reasons. N-desmethylsibutramine is a substance structurally similar to sibutramine. This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Tuesday, Jul 10, 2018
Issued at HKT 16:00